# DEFSEC Technologies Inc.: financial statements, quarterly

DFSC · Nasdaq · CIK 1889823 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/dfsc.md) · [Financials](/companies/dfsc/financials.md) · [Filings](/companies/dfsc/filings.md) · [Insiders](/companies/dfsc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dfsc/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | period not labelled (2020-09-30) | period not labelled (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [2.7](/filings/0001062993-24-001096.md) | [0.2](/filings/0001062993-24-021234.md) | [5.4](/filings/0001062993-24-021234.md) | [0.3](/filings/0001062993-24-021234.md) |
| Current assets | $m | not reported | [0.3](/filings/0001062993-23-001487.md) | [4.0](/filings/0001062993-23-001487.md) | [4.1](/filings/0001062993-23-001487.md) | [1.5](/filings/0001062993-24-001096.md) | [6.8](/filings/0001062993-24-021234.md) | [1.8](/filings/0001062993-24-021234.md) |
| Total assets | $m | not reported | [0.7](/filings/0001062993-23-001487.md) | [5.3](/filings/0001062993-23-001487.md) | [8.7](/filings/0001062993-23-001487.md) | [7.3](/filings/0001062993-24-001096.md) | [11.8](/filings/0001062993-24-021234.md) | [5.6](/filings/0001062993-24-021234.md) |
| Current liabilities | $m | not reported | [0.6](/filings/0001062993-23-001487.md) | [1.1](/filings/0001062993-23-001487.md) | [1.2](/filings/0001062993-23-001487.md) | [6.9](/filings/0001062993-24-001096.md) | [6.4](/filings/0001062993-24-021234.md) | [3.0](/filings/0001062993-24-021234.md) |
| Total liabilities | $m | not reported | [0.9](/filings/0001062993-23-001487.md) | [1.4](/filings/0001062993-23-001487.md) | [2.6](/filings/0001062993-23-001487.md) | [8.3](/filings/0001062993-24-001096.md) | [7.8](/filings/0001062993-24-021234.md) | [4.2](/filings/0001062993-24-021234.md) |
| Shareholders' equity | $m | [(1.4)](/filings/0001062993-23-001487.md) | [(0.2)](/filings/0001062993-23-001487.md) | [3.9](/filings/0001062993-24-001096.md) | [6.1](/filings/0001062993-24-021234.md) | [(1.0)](/filings/0001062993-24-021234.md) | [3.9](/filings/0001062993-24-021234.md) | [1.4](/filings/0001062993-24-021234.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 1,579,174 at 2024-09-30, from the cover of the [20-F/A filed 2025-10-14](/filings/0001062993-25-016037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.